An open-label, two-part, phase 2 clinical trial to investigate the safety and diagnostic performance of uPAR PET imaging for non-invasive classification of ISUP grades among patients with localised, untreated prostate cancer.
RecruitingCTIS2023-507111-35-00
Curasight A/SProstate Cancer
Start: 2024-06-03Target: 168Updated: 2025-11-17